A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs

Journal of Infectious Diseases

Volumn 212, Issue , 2015, Pages S384-S388

  Mire, Chad E ^a,b   Geisbert, Joan B ^a,b   Versteeg, Krista M ^a,b   Mamaeva, Natalia ^c,d   Agans, Krystle N ^a,b   Geisbert, Thomas W ^a,b   Connor, John H ^c,d  

^a Department of Pathology   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d National Emerging Infectious Diseases Laboratories Institute   (United States)

Author keywords

cross protection; Ebola virus; filovirus; Guinea pig; Marburg virus; trivalent; vaccine; vesicular stomatitis virus

Indexed keywords

FILOVIRUS VACCINE; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; VESICULAR STOMATITIS VIRUS VECTOR; VIRUS GLYCOPROTEIN; VIRUS VACCINE; VIRUS VECTOR; GLYCOPROTEIN; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS PROTECTION; DRUG EFFICACY; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; FEMALE; HARTLEY GUINEA PIG; MARBURG HEMORRHAGIC FEVER; MARBURGVIRUS; NONHUMAN; OUTBRED STRAIN; PRIORITY JOURNAL; SUDAN EBOLAVIRUS; VIREMIA; ZAIRE EBOLAVIRUS; ANIMAL; FILOVIRIDAE; FILOVIRUS INFECTION; GENE VECTOR; GUINEA PIG; IMMUNOLOGY; VESICULOVIRUS; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; FEMALE; FILOVIRIDAE; FILOVIRIDAE INFECTIONS; GENETIC VECTORS; GLYCOPROTEINS; GUINEA PIGS; VESICULOVIRUS; VIRAL VACCINES;

EID: 84943223963     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv126     Document Type: Article

References (15)

1. Feldmann H, Sanchez A, Geisbert TW. Filoviridae: Ebola and Marburg viruses. In: KDMaH PM, ed. Fields virology. 6th ed. Philadelphia: Lippincott Williams and Wilkins, 2013:923-56.
2. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea-preliminary report. N Engl J Med 2014; 371:1418-25.
3. Mire CE, Geisbert TW. Vaccines and antivirals for filoviruses. Biology and pathology of Rhabdo-and Filoviruses. Hackensack, NJ: World Scientific Publishing, Co., 2014.
4. Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis 1998; 178:651-61.
5. Bray M, Hatfill S, Hensley L, Huggins JW. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. J Comp Pathol 2001; 125:243-53.
6. Connolly BM, Steele KE, Davis KJ, et al. Pathogenesis of experimental Ebola virus infection in guinea pigs. J Infect Dis 1999; 179(suppl 1):S203-17.
7. Ebihara H, Zivcec M, Gardner D, et al. A Syrian golden hamster model recapitulating Ebola hemorrhagic fever. J Infect Dis 2013; 207:306-18.
8. Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB. Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg Infect Dis 2002; 8:503-7.
9. Warfield KL, Bradfute SB,Wells J, et al. Development and characterization of a mouse model for Marburg hemorrhagic fever. J Virol 2009; 83:6404-15.
10. Mire CE, Whitt MA. The protease-sensitive loop of the vesicular stomatitis virus matrix protein is involved in virus assembly and protein translation. Virology 2011; 416:16-25.
11. Lefrancois L, Lyles DS. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. II. Monoclonal antibodies of nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes. Virology 1982; 121:168-74.
12. Lefrancois L, Lyles DS. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology 1982; 121:157-67.
13. Ursic-Bedoya R, Mire CE, Robbins M, et al. Protection against lethal Marburg virus infection mediated by lipid encapsulated small interfering RNA. J Infect Dis 2014; 209:562-70.
14. Cross RW, Fenton KA, Geisbert JB, Mire CE, Geisbert TW. Modeling the disease course of Zaire ebolavirus infection in the outbred guinea pig. J Infect Dis 2015; 212(suppl 2):S305-15.
15. Marzi A, Ebihara H, Callison J, et al. Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy. J Infect Dis 2011; 204(suppl 3):S1066-74.